Modern diagnostic methods of paraneoplastic pemphigus

Cover Page


Cite item

Full Text

Abstract

Paraneoplastic pemphigus (PNP) is one of the least investigated and rare forms of bullous dermatoses, which comes from underlying neoplasm. The article presents a literature review of dermatologist`s longstanding international experience about etiology, pathogenesis, diagnostics and treatment of this disease. According to the research results of native and foreign authors systematization of modern diagnostic methods of PNP and detectable antigens was performed.

Conflict of interest: the authors state that there is no potential conflict of interest requiring disclosure in this article.

About the authors

A. A. Lepekhova

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: anfisa.lepehova@yandex.ru
Anfisa A. Lepekhova — Cand. Sci. (Med.), Assoc. Prof., V. A. Rakhmanov Department of Skin and Sexually Transmitted Diseases Russian Federation

N. P. Teplyuk

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: teplyukn@gmail.com
Natalia P. Teplyuk — Dr. Sci. (Med.), Prof., V. A. Rakhmanov Department of Skin and Sexually Transmitted Diseases Russian Federation

I. M. Bolotova

Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation

Author for correspondence.
Email: irinak120220@gmail.com
Irina M. Bolotova — Student Russian Federation

References

  1. Anhalt G. J., Chan K. S., Stanley J. R. et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990;323:1729–1735.
  2. Потекаев Н. С., Кечкер В. И., Николаева Л. П. Злокачественные новообразования и везикуло-буллезные дерматозы. Труды 1 ММИ. Т. 31. Гистохимические и биохимические исследования в дерматологии. М., 1964. С. 227–232.
  3. Nguyen V. T., Ndoye A., Bassler K. D. et al. Classification, clinical anifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol. 2001;137:193–206.
  4. Yong А. А., Tey H. L. Paraneoplastic pemphigus. Australasian Journal of Dermatology. 2013;54:241–250.
  5. Vassilieva S., Drenovska K., Manuelyan K. Autoimmune blistering dermatoses as systemic diseases. Clin Dermatol. 2014;32:364–375.
  6. Camisa C., Helm T. N. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol. 1993;129:883–886.
  7. Kaplan I., Hodak E., Ackerman L. et al. Neoplasms associated with paraneoplastic pemphigus: A review with emphasis on nonhematologic malignancy and oral mucosal manifestations. Oral Oncol. 2004;40:553–562.
  8. Lee S. E., Kim S. C. Paraneoplastic pemphigus. Dermatol Sin. 2010;28:1–14.
  9. Ostezan L. B., Fabré V. C., Caughman S. W., Swerlick R. A., Korman N. J., Callen J. P. Paraneoplastic pemphigus in the absence of a known neoplasm. J Am Acad Dermatol. 1995;33:312–315.
  10. Park G. T., Lee J. H., Yun S. J., Lee S. C., Lee J. B. Paraneoplastic pemphigus without an underlying neoplasm. Br J Dermatol. 2007;156:563–566.
  11. Verrini A., Cannata G., Cozzani E. et al. A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy. Acta Derm Venereol.2002;82:382–384.
  12. Anhalt G. J. Paraneoplastic pemphigus. The role of tumours and drugs. Br J Dermatol. 2001;144:1102–1104.
  13. Bazarbachi A., Bachelez H., Dehen L. et al. Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine. Ann Oncol. 1995;6:730–731.
  14. Lee M. S., Kossard S., Ho K. K. et al. Paraneoplastic pemphigus triggered by radiotherapy. Australas J Dermatol. 1995;36:206–210.
  15. Oursler J. R., Labib R. S., Ariss-Abdo L. et al. Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest. 1992;89:1775–1782.
  16. Zimmermann J., Bahmer F., Rose C. et al. Clinical and immunopathological spectrum of paraneoplastic pemphigus. J Dtsch Dermatol Ges. 2010;8:598–606.
  17. Ruhrberg C., Hajibagheri M. A., Parry D. A. et al. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biol. 1997;139:1835–1849.
  18. Sonnenberg A., Liem R. K. Plakins in development and disease. Exp Cell Res. 2007;313:2189–2203.
  19. Kanitakis J. Indirect immunofluorescence microscopy for the serological diagnosis of autoimmune blistering skin diseases: a review. J Clin Dermatol. 2001;19:614–621.
  20. Sehgal V. N., Srivastava G. Paraneoplastic pemphigus/ paraneoplastic autoimmune multiorgan syndrome. Int J Dermatol. 2009;48:162–169.
  21. Czernik A., Camilleri M., Pittelkow M. R., Grando S. A. Paraneoplastic autoimmune multiorgan syndrome: 20 years after. Int J Dermatol. 2011;50:905–914.
  22. Самцов А. В., Белоусова И. Э. Буллезные дерматозы: Монография. СПб.: ООО «Издательско-полиграфическая компания «Коста», 2012. 144 с.
  23. Wang L., Bu D., Yang Y. et al. Castleman’s tumours and production of autoantibody in paraneoplastic pemphigus. Lancet. 2004;14:525– 531.
  24. Seishima M., Oda M., Oyama Z. et al. Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma. Arch Dermatol. 2004;140:1500–1503.
  25. Aho S., Mahoney M. G., Uitto J. Plectin serves as an autoantigen in рaraneoplastic pemphigus. J Invest Dermatol. 1999;113:422–423.
  26. Billet S. E., Grando S. A., Pittelkow M. R. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity. 2006;39:617–630.
  27. Heymann W. R. Paraneoplastic autoimmune multiorgan syndrome. J Am Acad Dermatol. 2004;51:631–632.
  28. Zhu X., Zhang B. Paraneoplastic pemphigus. J Dermatol. 2007;34:503–511.
  29. Ashinoff R., Cohen R., Lipkin G. Castleman’s tumor and erosive lichen planus: coincidence or association? Report of a case. J Am Acad Dermatol. 1989;21:1076–1080.
  30. Lane J. E., Woody C., Davis L. S., Guill M. F., Jerath R. S. Paraneoplastic Autoimmune Multiorgan Syndrome (Paraneoplastic Pemphigus) in a Child: Case Report and Review of the Literature. Pediatrics. 2004;114:513–516.
  31. Joseph C. G., Darrah E., Shah A. A., Skora A. D., Casciola-Rosen L. A., Wigley F. M. et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science. 2014;343:152–157.
  32. Bowen G. M., Peters N. T., Fivenson D. P., Su L. D., Nousari H. C., Anhalt G. J. et al. Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading? Arch Dermatol. 2000;136:652–656.
  33. Chan L. S., Vanderlugt C. J., Hashimoto T., Nishikawa T., Zone J. J., Black M. M. et al. Epitope spreading: lessons from autoimmune skin disease. J Invest Dermatol. 1998;110:103–109.
  34. Wade M. S., Black M. M. Paraneoplastic pemphigus: A brief update. Australasian J Dermatol. 2005;46:1–10.
  35. Cummins D. L., Mimouni D., Tzu J., Owens N., Anhalt G. J., Meyerle J. H. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. J Am Acad Dermatol. 2007;56:153–159.
  36. Yee C., Biondi A., Wang X. H. et al. A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood. 1989;74:798–804.
  37. Nikolskaia O. V., Nousari C. H., Anhalt G. J. Paraneoplastic pemphigus in association with Castleman’s disease. Br J Dermatol. 2003;149:1143–1151.
  38. Hashimoto T. Immunopathology of paraneoplastic pemphigus. Clin Dermatol. 2001;19:675–682.
  39. Nousari H. C., Deterding R., Wojtczack H., Aho S., Uitto J., Hashimoto T. et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med. 1999;340:1406–1410.
  40. Hata T., Nishimoto S., Nagao K., Takahashi H., Yoshida K., Ohyama M. et al. Ectopic expression of epidermal antigens renders the lung a target organ in paraneoplastic pemphigus. J Immunol. 2013;191:83–90.
  41. Hwang Y.-Y., Chan J. C. Y., Trendell-Smith N. J., Kwong Y. L. Recalcitrant paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: response to prolonged rituximab and ciclosporin therapy. Intern Med J. 2014;44:1145–1146.
  42. Hsu C., Vega F., Grimes L. M., Hunt K. K. Follicular dendritic cell sarcoma and associated myasthenia gravis true, true, related. J Clin Oncol. 2011;29:369–371.
  43. Kim W. Y., Kim H., Jeon Y. K., Kim C. W. Follicular dendritic cell sarcoma with immature T-cell proliferation. Hum Pathol. 2010;41:129–133.
  44. Chorzelski T., Hashimoto T., Maciejewska B., Amagai M., Anhalt G. J., Jablonska S. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol. 1999;41:393–400.
  45. Jakubikova M., Pitha J., Latta J., Ehler E., Schutzner J. Myasthenia gravis, Castleman disease, pemphigus, and anti-phospholipid syndrome. Muscle Nerve. 2013;47:447–451.
  46. Wang R., Li J., Wang M., Hao H., Chen X. et al. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis. Br J Dermatol. 2015;172:968–975.
  47. Абрамова Т. В. Пузырчатка: клиника, иммунопатогенез и патогенетическая терапия (клинико-экспериментальное исследование). 2018.
  48. Zhang B., Zheng R., Wang J. et al. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients. J Invest Dermatol. 2006;126:832–840.
  49. Huang Y., Li J., Zhu X. Detection of anti-envoplakin and antiperiplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus. Arch Dermatol Res. 2009;301:703–709.
  50. Колос Ю. В., Лукьянов А. М. Буллезные дерматозы: диагностическое значение определения аутоантител методом иммуноферментного анализа. Здравоохранение (Минск). 2014;(3):55–61.
  51. Helou J., Allbritton J., Anhalt G. Accuracy of indirect immunofluorescence in the diagnosis of para-neoplastic pemphigus. J Am Acad Dermatol. 1995;32:441–447.
  52. Wang J., Zhu X., Li R., Tu P., Wang R., Zhang L. et al. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China. Arch Dermatol. 2005;141:1285–1293.
  53. Gergely L., Váróczy L., Vadász G. et al. Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A. Acta Haematol. 2003;109:202–205.
  54. Reich K., Brinck U., Letschert M. et al. Graft-versus-host diseaselike immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus. Br J Dermatol. 1999;141:739–746.
  55. Williams J. V., Marks J. G., Billingsley E. M. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol. 2000;142:506–508.
  56. Anhalt G. J. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc. 2004;9:29–33.
  57. Hayag M. V., Cohen J. A., Kerdel F. A. Immunoablative highdose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. J Am Acad Dermatol. 2000;43:1065–1069.
  58. Sklavounou A., Laskaris G. Paraneoplastic pemphigus: a review. Oral Oncol. 1998;35:437–440.
  59. Tilakaratne W. M., Dissanayake M. Paraneoplastic pemphigus: a case report and review of literature. Oral Dis. 2005;11:326–329.
  60. Porro A. M., Caetano L. de V., Maehara L. de S., Enokihara M. M. Non-classical forms of pemphigus: pemphigus herpetiformis, gA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus. An Bras Dermatol. 2014;89:96–106.
  61. Wieczorek M., Czernik A. Paraneoplastic pemphigus: a short review. Clin Cosmet Investig Dermatol. 2016;9:291–295.
  62. Ohzono A., Sogame R., Li X., Teye K., Tsuchisaka A., Numata S. et al. Clinical and immunological findings in 104 cases of paraneoplastic pemphigus. Br J Dermatol. 2015;173:1447–1452.
  63. Joly P., Richard C., Gilbert D., Courville P., Chosidow O., Roujeau J. C. et al. Sensitivity and specificity of clinical, histologic, and immuno-logic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol. 2000;43:619–626.
  64. Poot A. M., Siland J., Jonkman M. F., Pas H. H., Diercks G. F. Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus. Br J Dermatol. 2016;174:912–915.
  65. Mimouni D., Anhalt G. J., Lazarova Z., Aho S., Kazerounian S., Kouba D. J. et al. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol. 2002;147:725–732.
  66. Poot A. M., Diercks G. F., Kramer D., Schepens I., Klunder G., Hashimoto T. et al. Laboratory diagnosis of paraneoplastic pemphigus. Br J Dermatol. 2013;169:1016–1024.
  67. Liu A. Y., Valenzuela R., Helm T. N., Camisa C., Melton A.L., Bergfeld W. F. Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol. 1993;28:696–699.
  68. Tsuchisaka A., Kawano H., Yasukochi A. et al. Immunological and statistical studies of anti-BP180 antibodies in paraneoplastic pemphigus. J Invest Dermatol. 2014;134:2283–2287.
  69. Ishii N., Teye K., Fukuda S. et al. Anti-desmocollin autoantibodies in nonclassical pemphigus. Br J Dermatol. 2015;173:59–68.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Lepekhova A.A., Teplyuk N.P., Bolotova I.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies